Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
Called optiPRM, the approach could help detect cancer neoantigens in patient tumor samples for applications like the development of personalized cancer vaccines.
Spear Bio Raises $45M in Series A Round for Protein-Based Diagnostics Using qPCR Instruments
Bio-Techne co-led the round, with proceeds intended to accelerate development and scale up manufacturing.
TD Cowen Initiates Coverage of Biodesix With Buy Rating
Analyst Dan Brennan wrote that lung nodule diagnostics is about a $4 billion market that is only about 1 percent penetrated, with Biodesix the only commercial player.
The firm said its multi-omic AidaBreast test can help stratify patients by their expected benefit from radiation therapy and aid treatment decisions.
The company was successful in identifying protein panels that can detect the presence of one of 18 types of solid tumor, at early stages, from a blood sample.